The University of Washington was awarded a $507,517 Project Grant (R01EB036076) by the National Institute of Biomedical Imaging and Bioengineering to develop novel, synthetic therapies for stabilizing trauma victims in the critical "golden hour" after injury. The key objectives are to engineer low volume resuscitants that provide fluid resuscitation while preserving the patient's coagulation system, and immune-modulating polymers that attenuate inflammation and neutralize reactive oxygen species. The project aims to lead to new innovations for trauma medicine that can be used outside the hospital setting. This falls under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program, which supports research and development of innovative biomedical technologies, imaging techniques, and engineering solutions to advance understanding of human health.
Generated 3/18/25, 4:32 AM